CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT)

Physiology and Behavior

Volumn 97, Issue 1, 2009, Pages 14-20

  Munsch, Simone ^a   Biedert, Esther ^a   Meyer, Andrea H ^a,c   Herpertz, Stephan ^b   Beglinger, Christoph ^d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Faculty of Psychology   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

CBT trial; CCK; Ghrelin; Obese BED individuals; PYY

Indexed keywords

CHOLECYSTOKININ; GHRELIN; PEPTIDE YY;

ADULT; ARTICLE; BINGE EATING DISORDER; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; FOOD COMPOSITION; HORMONE RELEASE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; SATIETY;

BULIMIA NERVOSA; CASE-CONTROL STUDIES; CHOLECYSTOKININ; COGNITIVE THERAPY; EATING; FEMALE; GHRELIN; HUMANS; MALE; MIDDLE AGED; OBESITY; PEPTIDE YY; SEVERITY OF ILLNESS INDEX;

EID: 62849090440     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2009.01.015     Document Type: Article

References (44)

1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders: DSM-IV (1994), American Psychiatric Association, Washington DC
2. Bulik C.M., and Reichborn-Kjennerud T. Medical morbidity in binge eating disorder. Int J Eat Disord 34 (2003) 39-46 Suppl
3. Spitzer R.L., Devlin M.J., Walsh B.T., Hasin D., Wing R.R., Marcus M.D., et al. Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eat Disord 11 (1992) 191-203
4. Spitzer R.L., Yanovski S., Wadden T., Wing R., Marcus M.D., Stunkard A., et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 13 (1993) 137-153
5. Munsch S., Becker E., Meyer A., S S., and Margraf J. Recurrent binge eating (RBE) and its characteristics in a sample of young women in Germany. Eur Eat Disord Rev 15 (2007) 385-399
6. Chambless D.L., and Ollendick T.H. Empirically supported psychological interventions: controversies and evidence. Annu Rev Psychol 52 (2001) 685-716
7. Ouwens M.A., van Strien T., and van der Staak C.P.F. Tendency toward overeating and restraint as predictors of food consumption. Appetite 40 (2003) 291-298
8. Geary N. Endocrine controls of eating: CCK, leptin, and ghrelin. Physiol Behav 81 (2004) 719-733
9. Beglinger C., and Degen L. Fat in the intestine as a regulator of appetite-role of CCK. Physiol Behav 83 (2004) 617-621
10. Beglinger C., and Degen L. Gastrointestinal satiety signals in humans-physiologic roles for GLP-1 and PYY?. Physiol Behav 89 (2006) 460-464
11. Strader A.D., and Woods S.C. Gastrointestinal hormones and food intake. Gastroenterology 128 (2005) 175-191
12. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86 (2001) 4753-4758
13. Geliebter A., Yahav E.K., Gluck M.E., and Hashim S.A. Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder. Physiol Behav 81 (2004) 735-740
14. Monteleone P., Martiadis V., Fabrazzo M., Serritella C., and Maj M. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med 33 (2003) 1387-1394
15. Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M.S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
16. Misra M., Miller K.K., Tsai P., Gallagher K., Lin A., Lee N., et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91 (2006) 1027-1033
17. Baranowska B., Radzikowska M., Wasilewska-Dziubinska E., Roguski K., and Borowiec M. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2 (2000) 99-103
18. Phillipp E., Pirke K.M., Kellner M.B., and Krieg J.C. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 48 (1991) 2443-2450
19. Pirke K.M., Kellner M.B., Friess E., Krieg J.C., and Fichter M.M. Satiety and cholecystokinin. Int J Eat Disord 15 (1994) 63-69
20. Monteleone P., Fabrazzo M., Tortorella A., Martiadis V., Serritella C., and Maj M. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 30 (2005) 243-250
21. Stock S., Leichner P., Wong A.C., Ghatei M.A., Kieffer T.J., Bloom S.R., et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90 (2005) 2161-2168
22. Geliebter A., Gluck M.E., and Hashim S.A. Plasma ghrelin concentrations are lower in binge-eating disorder. J Nutr 135 (2005) 1326-1330
23. J. Margraf, A. Ehlers, Beck Angstinventar Deutsche Version (BAI). Bern: Hans Huber; in press.
24. Hautzinger M., Bailer M., Worall H., and Keller F. Beck-Depressions-Inventar (BDI) (1995), Hans Huber, Bern
25. Hilbert A., Tuschen Caffier B., and Ohms M. Eating Disorders Examination: A German version of the Structured Eating Disorder Interviews Eating Disorder Examination: Deutschsprachige Version des strukturierten Essstorungsinterviews. Diagnostica 50 (2004) 98-106
26. Tuschen Caffier B., Pook M., and Frank M. Evaluation of manual-based cognitive-behavioral therapy for bulimia nervosa in a service setting. Behav Res Ther 39 (2001) 299-308
27. Derogatis L.R. SCL-90-R. Administration, Scoring and Procedures Manual (1995), National Computer Systems Inc., Minneapolis, Minn.
28. Vierter schweizerischer Ernährungsbericht: Bundesamt für Gesundheit; 1998.
29. Harris J.A., and Benedict F.G. A biometric study of human basal metabolism. Proc Natl Acad Sci U S A 4 (1918) 370-373
30. Müller M.J., Bosy-Westphal A., Klaus S., Kreymann G., Lührmann P.M., Neuhäuser-Berthold M., et al. World Health Organization equations have shortcomings for predicting resting energy expenditure in persons from a modern, affluent population: generation of a new reference standard from a retrospective analysis of a German database of resting energy expenditure. Am J Clin Nutr 80 (2004) 1379-1390
31. Degen L., Matzinger D., Drewe J., Nissle S., Maecke H., Lengsfeld H., et al. Role of free fatty acids in regulating gastric emptying and gallbladder contraction. Digestion 74 (2006) 131-139
32. Gutzwiller J.P., Degen L., Matzinger D., Prestin S., and Beglinger C. Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am J Physiol Regul Integr Comp Physiol 287 (2004) R562-567
33. Munsch S. Kognitive Verhaltenstherapie bei Binge Eating Disorder (2003), Beltz PVU, Weinheim
34. Munsch S., Biedert E., Meyer A., Michael T., B S., Tuch A., et al. A randomized comparison of cognitive behavioral therapy and behavioral weight management treatment for overweight individuals with binge eating disorder. Int J Eat Disord 40 (2007) 102-113
35. Wilfley D.E., Welch R.R., Stein R.I., Spurrell E.B., Cohen L.R., Saelens B.E., et al. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 59 (2002) 713-721
36. SPSS. SPSS for Windows, Rel. 14.0 (2001), SPSS inc., Chicago
37. Geliebter A., Hashim S.A., and Gluck M.E. Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED). Physiol Behav 94 (2008) 696-699
38. Brennan I.M., Otto B., Feltrin K.L., Meyer J.H., Horowitz M., and Feinle-Bisset C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides 28 (2007) 607-611
39. Monteleone P., Fabrazzo M., Tortorella A., Martiadis V., Serritella C., and Maj M. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 30 (2005) 243-250
40. Morpurgo P.S., Resnik M., Agosti F., Cappiello V., Sartorio A., and Spada A. Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program. J Endocrinol Investig 26 (2003) 723-727
41. Hebebrand J., Blum W.F., Barth N., Coners H., Englaro P., Juul A., et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 2 (1997) 330-334
42. Nasser J.A., Gluck M.E., and Geliebter A. Impulsivity and test meal intake in obese binge eating women. Appetite 43 (2004) 303-307
43. Nederkoorn C., Braet C., Van Eijs Y., Tanghe A., and Jansen A. Why obese children cannot resist food: the role of impulsivity. Eat Behav 7 (2006) 315-322
44. Mikami A.Y., Hinshaw S.P., Patterson K.A., and Lee J.C. Eating pathology among adolescent girls with attention-deficit/hyperactivity disorder. J Abnorm Psychology 117 (2008) 225-235